Syndecan-4 as a Marker of Endothelial Dysfunction in Patients with Resistant Hypertension

(1) Background: Arterial hypertension (HTN) is one of the most relevant cardiovascular risk factors. Nowadays multiple pharmaceutical treatment options exist with novel interventional methods (e.g., baroreflex activation therapy (BAT)) as a last resort to treat patients with resistant HTN. Although...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipphardt, Mark, Dihazi, Hassan, Maas, Jens-Holger, Schäfer, Ann-Kathrin, Amlaz, Saskia I., Ratliff, Brian B., Koziolek, Michael J., Wallbach, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564403/
https://www.ncbi.nlm.nih.gov/pubmed/32971813
http://dx.doi.org/10.3390/jcm9093051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564403/
https://www.ncbi.nlm.nih.gov/pubmed/32971813
http://dx.doi.org/10.3390/jcm9093051

Ejemplares similares